Dr. Pergolizzi outlines some of the newer analgesic candidates under investigation, their mechanisms of action, and why trial design for these investigations may not always mimic clinical practice. Also discussed are new targets for analgesic testing.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox